顯示第 17 至 28 項結果，共 28 項
-
Anti-CD8 [YTC 182.20] (Ab01039-35.0-BT)
-
Anti-CD8a [YTC 141.1HL] (Ab01038-35.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-35.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-35.0)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-36.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-36.0)
-
Anti-Glycoprotein Complex [37.7H] (Ab01102-35.0-BT)
-
Anti-Glycoprotein Complex [37.7H] (Ab01102-35.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-35.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-35.0)